PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 162 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,553,711 | +79.6% | 1,383,678 | +186.1% | 0.04% | +80.0% |
| Q2 2023 | $6,431,614 | +6205.5% | 483,580 | +2005.6% | 0.02% | – |
| Q2 2022 | $102,000 | -77.0% | 22,966 | +80.7% | 0.00% | -100.0% |
| Q2 2021 | $444,000 | -91.8% | 12,711 | -92.2% | 0.00% | -91.7% |
| Q1 2021 | $5,398,000 | -17.9% | 162,061 | -36.1% | 0.02% | -17.2% |
| Q4 2020 | $6,578,000 | +7460.9% | 253,582 | +901.7% | 0.03% | – |
| Q2 2020 | $87,000 | -97.8% | 25,315 | -96.8% | 0.00% | -100.0% |
| Q4 2019 | $4,039,000 | -39.9% | 785,846 | -39.6% | 0.01% | -48.0% |
| Q3 2019 | $6,718,000 | -27.8% | 1,301,892 | -15.4% | 0.02% | -26.5% |
| Q2 2019 | $9,308,000 | +86.8% | 1,538,409 | +123.2% | 0.03% | +78.9% |
| Q1 2019 | $4,984,000 | – | 689,361 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |